Prophylactic urethral stenting with Memokath® 028SW in prostate cancer patients undergoing prostate 125I seed implants: phase I/II study

Prophylactic urethral stenting with Memokath® 028SW in prostate cancer patients undergoing prostate 125I seed implants: phase I/II study

Purpose: To study the feasibility/toxicity of urethral stenting with the Memokath® 028SW stent in patients undergoing prostate implant (PI) for prostate adenocarcinoma. Material and methods: An Investigational Device Exemption from the Food and Drug Administration (FDA) and institutional review boar...

Full description

Bibliographic Details
Main Authors: Samuel T. Chao, Kenneth Angermeier, Eric A. Klein, Chandana A. Reddy, James C. Ulchaker, Andrew Stephenson, Steven Campbell, Jay P. Ciezki
Format: Article
Language:English
Published: Termedia Publishing House 2011-03-01
Series:Journal of Contemporary Brachytherapy
Subjects:
urethral stent
prostate brachytherapy
prostate cancer
urethral obstruction
Online Access:http://www.termedia.pl/Clinical-Investigations-Prophylactic-urethral-stenting-with-Memokath-028SW-in-prostate-cancer-patients-undergoing-prostate-125I-seed-implants-phase-I-II-study,54,16439,1,1.html

Internet

http://www.termedia.pl/Clinical-Investigations-Prophylactic-urethral-stenting-with-Memokath-028SW-in-prostate-cancer-patients-undergoing-prostate-125I-seed-implants-phase-I-II-study,54,16439,1,1.html

Similar Items